TNF-α and IL-1β are the main inflammatory cytokines in the progression of RA [4,13]; therefore, 50 ng/mL TNF-α and 50 ng/mL IL-1β are used to treat SF-MSCs and induce RA inflammation. Here, IL1B is linked to rheumatoid arthritis.